Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 1/20 | 0.44 |
| ▸ | THRB | P10828 | 1/20 | 0.36 |
| ▸ | CA2 | P00918 | 2/20 | 0.33 |
| ▸ | F2 | P00734 | 1/20 | 0.32 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.32 |
| ▸ | PRSS2 | P07478 | 1/20 | 0.32 |
| ▸ | PRSS3 | P35030 | 1/20 | 0.32 |
| ▸ | CA1 | P00915 | 1/20 | 0.31 |
| ▸ | MMP1 | P03956 | 1/20 | 0.31 |
| ▸ | MMP2 | P08253 | 1/20 | 0.31 |
| ▸ | MMP9 | P14780 | 1/20 | 0.31 |
| ▸ | MMP8 | P22894 | 1/20 | 0.31 |
| ▸ | MMP13 | P45452 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL344486 | 1.00 | LMNA (0.44) | LMNATHRBCA2F2PRSS1 | |
| SCHEMBL345309 | 1.00 | LMNA (0.44) | LMNATHRBCA2F2PRSS1 | |
| SCHEMBL394687 | 1.00 | LMNA (0.44) | LMNATHRBCA2F2PRSS1 | |
| SCHEMBL397274 | 1.00 | LMNA (0.44) | LMNATHRBCA2F2PRSS1 | |
| SCHEMBL7128082 | 1.00 | LMNA (0.44) | LMNATHRBCA2F2PRSS1 | |
| SCHEMBL637823 | 1.00 | LMNA (0.44) | LMNATHRBCA2F2PRSS1 | |
| SCHEMBL394637 | 1.00 | LMNA (0.44) | LMNATHRBCA2F2PRSS1 | |
| SCHEMBL396607 | 1.00 | LMNA (0.44) | LMNATHRBCA2F2PRSS1 | |
| SCHEMBL4350577 | 1.00 | LMNA (0.44) | LMNATHRBCA2F2PRSS1 | |
| SCHEMBL2050322 | 1.00 | LMNA (0.44) | LMNATHRBCA2F2PRSS1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 172 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117942772-A | Anti-pollution film and preparation method thereof | 中国石油化工股份有限公司 | 2024-04-30 | — | — | CN | claimed |
| CN-108923046-B | Preparation method of nano porous lithium-rich lithium iron phosphate material | 江苏乐能电池股份有限公司 | 2021-08-31 | — | — | CN | claimed |
| CN-111117787-B | Bactericidal acaricidal surfactant, preparation method thereof and laundry detergent | 万华化学集团股份有限公司 | 2021-05-14 | — | — | CN | claimed |
| CN-111117787-A | Bactericidal acaricidal surfactant, preparation method thereof and laundry detergent | 万华化学集团股份有限公司 | 2020-05-08 | — | — | CN | claimed |
| CN-108923046-A | A kind of preparation method of nanoporous richness lithium LiFePO 4 material | 江苏乐能电池股份有限公司 | 2018-11-30 | — | — | CN | claimed |
| EP-2246134-B1 | Stabilized lithium metal powder for Li-ion application, composition and process | FMC CORP (US) | 2014-03-12 | — | — | EP | claimed |
| US-20020160272-A1 | Process for producing a modified electrolyte and the modified electrolyte | KABUSHIKI KAISHA TOYOTA CHUO (JP) | 2002-10-31 | — | — | US | claimed |
| EP-3635022-B1 | METHODS FOR MAKING FUNCTIONALIZED FLUORINATED MONOMERS, FLUORINATED MONOMERS, AND COMPOSITIONS FOR MAKING THE SAME | ETNA TEC LTD (US) | 2025-05-21 | — | — | EP | disclosed |
| CN-117942772-A | Anti-pollution film and preparation method thereof | 中国石油化工股份有限公司 | 2024-04-30 | — | — | CN | disclosed |
| US-11939415-B1 | Polysiloxane-based objects and 3-dimensional printing method for making the same | TRIAD NATIONAL SECURITY, LLC (US) | 2024-03-26 | — | — | US | disclosed |
| US-11911955-B1 | System and method embodiments for modifying gas content in printable compositions for additive manufacturing | TRIAD NATIONAL SECURITY, LLC (US) | 2024-02-27 | — | — | US | disclosed |
| CN-110770271-B | Method for preparing functionalized fluorinated monomers, fluorinated monomers and compositions for preparing same | 埃特纳科技有限公司 | 2023-04-18 | — | — | CN | disclosed |
| US-11492318-B2 | Methods for making functionalized fluorinated monomers, fluorinated monomers, and compositions for making the same | ETNA-TEC, LTD. (US) | 2022-11-08 | — | — | US | disclosed |
| WO-2002036639-A2 | FLUORINATED ZWITTERIONIC COCATALYST ACTIVATORS FOR OLEFIN POLYMERIZATION | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2002-05-10 | — | — | WO | disclosed |
| EP-0921109-B1 | METHOD FOR PURIFYING 1,1,1,3,3-PENTAFLUOROPROPANE | DAIKIN IND LTD (JP) | 2002-01-23 | — | — | EP | disclosed |
| US-20010020075-A1 | Catalyst component for addition polymerization, catalyst for addition polymerization, and process for producing addition polymer | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2001-09-06 | — | — | US | disclosed |
| EP-1113026-A2 | Catalyst component for addition polymerization, catalyst for addition polymerization, and process for producing addition polymer | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2001-07-04 | — | — | EP | disclosed |
| US-6191328-B1 | EXTRACTION; PURIFICATION | DAIKIN INDUSTRIES, LTD. (JP) | 2001-02-20 | — | — | US | disclosed |
| EP-0921109-A1 | METHOD FOR PURIFYING 1,1,1,3,3-PENTAFLUOROPROPANE | DAIKIN INDUSTRIES, LIMITED (JP) | 1999-06-09 | — | — | EP | disclosed |
| US-4701224-A | Water soluble condensation soldering flux | AMERICAN TELEPHONE AND TELEGRAPH COMPANY, AT&T BELL LABORATORIES (US) | 1987-10-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11492318-B2 | Methods for making functionalized fluorinated monomers, fluorinated monomers, and compositions for making the same | ALKBH3, FTO, ALK | LMNA 1234/4885THRB 2047/4885CA2 2671/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.